Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 66.96
(-1.18%)
INR 66.96
(-1.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.06 Billion INR | -20.76% |
| 2022 | 1.34 Billion INR | 59.94% |
| 2021 | 837.91 Million INR | 41.58% |
| 2020 | 591.85 Million INR | 390.93% |
| 2019 | 120.55 Million INR | 285.72% |
| 2018 | 31.25 Million INR | 157160.8% |
| 2017 | -19.9 Thousand INR | 99.72% |
| 2016 | -7.06 Million INR | -1829.64% |
| 2015 | -366.32 Thousand INR | -129.94% |
| 2014 | 1.22 Million INR | -36.58% |
| 2013 | 1.92 Million INR | 123.97% |
| 2012 | 861.33 Thousand INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 247.74 Million INR | -11.16% |
| 2023 Q4 | 278.86 Million INR | -8.34% |
| 2023 Q3 | 304.24 Million INR | 18.84% |
| 2023 Q1 | 256.42 Million INR | -13.38% |
| 2023 FY | 1.06 Billion INR | -20.76% |
| 2023 Q2 | 256 Million INR | -0.16% |
| 2022 Q1 | 296.02 Million INR | 5.32% |
| 2022 FY | 1.34 Billion INR | 59.94% |
| 2022 Q4 | 296.02 Million INR | -12.54% |
| 2022 Q3 | 338.47 Million INR | 32.0% |
| 2022 Q2 | 256.42 Million INR | -13.38% |
| 2021 Q3 | 197.27 Million INR | 2.94% |
| 2021 Q2 | 191.63 Million INR | 14.11% |
| 2021 Q4 | 281.08 Million INR | 42.48% |
| 2021 FY | 837.91 Million INR | 41.58% |
| 2021 Q1 | 167.93 Million INR | 11.03% |
| 2020 Q3 | 164.5 Million INR | 11.19% |
| 2020 FY | 591.85 Million INR | 390.93% |
| 2020 Q2 | 147.95 Million INR | 15.46% |
| 2020 Q4 | 151.25 Million INR | -8.05% |
| 2020 Q1 | 128.14 Million INR | 311.11% |
| 2019 Q4 | 31.17 Million INR | -29.48% |
| 2019 Q2 | 24.72 Million INR | 20.81% |
| 2019 Q1 | 20.46 Million INR | 56.12% |
| 2019 FY | 120.55 Million INR | 285.72% |
| 2019 Q3 | 44.19 Million INR | 78.77% |
| 2018 Q1 | - INR | 100.0% |
| 2018 FY | 31.25 Million INR | 157160.8% |
| 2018 Q4 | 13.1 Million INR | -11.29% |
| 2018 Q3 | 14.77 Million INR | 338.38% |
| 2018 Q2 | 3.37 Million INR | 0.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 FY | -19.9 Thousand INR | 99.72% |
| 2017 Q4 | -19.4 Thousand INR | 0.0% |
| 2017 Q3 | - INR | 0.0% |
| 2017 Q1 | - INR | 100.0% |
| 2016 Q1 | 18.75 Thousand INR | -55.86% |
| 2016 FY | -7.06 Million INR | -1829.64% |
| 2016 Q4 | -6.17 Million INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q2 | - INR | -100.0% |
| 2015 Q3 | 227 Thousand INR | 1058.16% |
| 2015 Q2 | 19.6 Thousand INR | -88.76% |
| 2015 Q1 | 174.33 Thousand INR | -53.83% |
| 2015 FY | -366.32 Thousand INR | -129.94% |
| 2015 Q4 | 42.48 Thousand INR | -81.29% |
| 2014 Q3 | 766 Thousand INR | 0.0% |
| 2014 FY | 1.22 Million INR | -36.58% |
| 2014 Q4 | 377.54 Thousand INR | -50.71% |
| 2013 FY | 1.92 Million INR | 123.97% |
| 2012 FY | 861.33 Thousand INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|